NBC Securities Inc. Acquires New Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
NBC Securities Inc. bought a new position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to its most recent filing with the SEC. The institutional investor bought 123 shares of the biopharmaceutical company’s stock, valued at approximately $78,000. Other hedge funds have also made changes to their positions in the […]
